Praxis Precision Medicines (PRAX) Net Cash Flow (2019 - 2026)
Praxis Precision Medicines (PRAX) posted quarterly Net Cash Flow of $179.0 million for Q1 2026, up 459.41% year-over-year from $32.0 million in Q1 2025, and down 13.86% quarter-over-quarter from $207.8 million in Q4 2025.
Praxis Precision Medicines (PRAX) Net Cash Flow (2019 - 2026) Analysis & Trends
Praxis Precision Medicines' Net Cash Flow history runs 8 years deep, the most recent figure standing at $179.0 million for Q1 2026.
- In Q1 2026, Net Cash Flow rose 459.41% year-over-year to $179.0 million; the TTM figure through Mar 2026 stood at $370.8 million (up 2628.83% YoY), while the FY2025 annual figure was $142.0 million, up 5.88% from the prior year.
- Net Cash Flow for Q1 2026 stood at $179.0 million, down from $207.8 million in the prior quarter.
- The five-year high for Net Cash Flow was $207.8 million in Q4 2025, with the low at -$61.4 million in Q1 2022.
- The 5-year median for Net Cash Flow is -$825000.0 (2022), against an average of $23.4 million.
- The sharpest annual moves came in 2023 and 2026: Net Cash Flow sank 2298.18% in 2023, then surged 459.41% in 2026.
- Praxis Precision Medicines' Net Cash Flow stood at -$825000.0 in 2022, then tumbled by 2298.18% to -$19.8 million in 2023, then jumped by 336.17% to $46.7 million in 2024, then surged by 344.72% to $207.8 million in 2025, then fell by 13.86% to $179.0 million in 2026.
- Business Quant data shows PRAX's Net Cash Flow at $179.0 million in Q1 2026, $207.8 million in Q4 2025, and -$7.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 407.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 17.81 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -496,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.14 Mn |
| 10 | Praxis Precision Medicines | 10.24 Bn | 9.48 Bn | - | -61.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -61.99 Mn |
| Jun 30, 2026 | -61.99 Mn |
| Mar 31, 2026 | 179.00 Mn |
| Mar 31, 2026 | 179.00 Mn |
| Dec 31, 2025 | 207.80 Mn |
| Dec 31, 2025 | 207.80 Mn |
| Sep 30, 2025 | -7.89 Mn |
| Sep 30, 2025 | -7.89 Mn |
| Jun 30, 2025 | -8.15 Mn |
| Jun 30, 2025 | -8.15 Mn |
| Mar 31, 2025 | -49.81 Mn |
| Mar 31, 2025 | -49.81 Mn |
| Dec 31, 2024 | 46.73 Mn |
| Dec 31, 2024 | 46.73 Mn |
| Sep 30, 2024 | 23.50 Mn |
| Sep 30, 2024 | 23.50 Mn |
| Jun 30, 2024 | -6.84 Mn |
| Jun 30, 2024 | -6.84 Mn |
| Mar 31, 2024 | 70.68 Mn |
| Mar 31, 2024 | 70.68 Mn |